Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial-Reference-Cited by-同舟云学术

Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial

Published:2011-04 Issue:9773 Volume:377 Page:1241-1247
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Silber Sigmund,Windecker Stephan,Vranckx Pascal,Serruys Patrick W

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery;Moses;N Engl J Med,2003

2. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease;Stone;N Engl J Med,2004

3. Stent thrombosis redux — the FDA perspective;Farb;N Engl J Med,2007

4. Overview of the 2006 Food and Drug Administration Circulatory System Devices Panel meeting on drug-eluting stent thrombosis;Slottow;Catheter Cardiovasc Interv,2007

5. Clinical end points in coronary stent trials: a case for standardized definitions;Cutlip;Circulation,2007

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Cardiovascular Frontiers: A Dive Into Cutting-Edge Innovations in Coronary Stent Technology;Cardiology in Review;2024-05-06

2. Quantitative Coronary Angiography vs Intravascular Ultrasonography to Guide Drug-Eluting Stent Implantation;JAMA Cardiology;2024-05-01

3. Deteriorative Effect of a Combination of Hypertriglyceridemia and Low High-Density Lipoprotein Cholesterolemia on Target Lesion Revascularization after Everolimus-Eluting Stent Implantation;Journal of Atherosclerosis and Thrombosis;2023-12-01

4. Three Time Loser or Third Time’s the Charm? PCI of Recurrent Restenosis After Overlapped Drug-Eluting Stents;Journal of the Society for Cardiovascular Angiography & Interventions;2023-09

5. Resistant Drug-Eluting Stent Restenosis and Resurrection of Intracoronary Brachytherapy: The Lazarus of Contemporary Coronary Intervention;Journal of the Society for Cardiovascular Angiography & Interventions;2023-01